Phase Separation in Kidney Diseases: Autosomal Dominant Polycystic Kidney Disease and Beyond

被引:2
|
作者
Zhang, Lirong [1 ]
Liu, Zhiheng [1 ]
Lu, Yumei [1 ]
Nie, Jing [2 ,3 ]
Chen, Yupeng [1 ,4 ]
机构
[1] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Prov & Minist Cosponsored Collaborat Innovat Ctr, Tianjin, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Guangdong Prov Inst Nephrol, Natl Clin Res Ctr Kidney Dis,State Key Lab Organ, Guangzhou, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Div Nephrol, North Guangzhou Ave 1838, Guangzhou 510515, Peoples R China
[4] Tianjin Med Univ, Dept Biochem & Mol Biol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China
关键词
Phase separation; Autosomal dominant polycystic kidney disease; Metabolism; Epigenetics; Kidney diseases; LIQUID; TRANSITION; PROMOTES; GRANULE; SWITCH;
D O I
10.1159/000530250
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The formation of biomolecular condensates via phase separation has emerged as a fundamental principle underlying the spatiotemporal coordination of biological activities in cells. Aberrant biomolecular condensates often directly regulate key cellular process involved in the pathogenesis of human diseases, including kidney diseases. Summary: In this review, we summarize the physiological roles of phase separation and methodologies for phase separation studies. Taking autosomal dominant polycystic kidney disease as an example, we discuss recent advances toward elucidating the multiple mechanisms involved in kidney pathology arising from aberrant phase separation. We suggest that dysregulation of phase separation contributes to the pathogenesis of other important kidney diseases, including kidney injury and fibrosis. Key Messages: Phase separation provides a useful new concept to understand the mechanisms underlying kidney disease development. Targeting aberrant phase-separated condensates offers new therapeutic avenues for combating kidney diseases.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 50 条
  • [1] Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases
    Torres, VE
    Harris, PC
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (01): : 40 - 55
  • [2] Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases
    Vicente E Torres
    Peter C Harris
    Nature Clinical Practice Nephrology, 2006, 2 : 40 - 55
  • [3] Autosomal dominant polycystic kidney disease
    Simms, Roslyn J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [4] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283
  • [5] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [6] AUTOSOMAL DOMINANT POLYCYSTIC DISEASE OF THE KIDNEY
    FICK, G
    WEBER, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (30) : 1160 - 1164
  • [7] Autosomal Dominant Polycystic Kidney Disease
    Zacharia, George Sarin
    Rajakumari, P. K.
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2013, 3 (04): : 194 - 195
  • [8] Autosomal dominant polycystic kidney disease
    Silverman, Jonathan
    Desai, Chaitanya
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (10): : 442 - 447
  • [9] Autosomal dominant polycystic kidney disease
    Cornec-Le Gall, Emilie
    Alam, Ahsan
    Perrone, Ronald D.
    LANCET, 2019, 393 (10174): : 919 - 935
  • [10] Autosomal dominant polycystic kidney disease
    Pirson, Y
    Chauveau, D
    Watson, ML
    Zeier, M
    Breuning, MH
    M S-MEDECINE SCIENCES, 1997, 13 (01): : 37 - 44